276P Development and external validation of an artificial intelligence (AI)-based machine learning model (ML) for predicting pathological complete response (pCR) in hormone-receptor (HoR)-positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT)

Autor: Mastrantoni, L., Garufi, G., Di Monte, E., Arcuri, G., Frescura, V., Maliziola, N., Rotondi, A., Giordano, G., Carbognin, L., Fabi, A., Paris, I., Franceschini, G., Orlandi, A., Palazzo, A., Puglisi, F., Dieci, M.V., Milella, M., Scambia, G., Tortora, G., Bria, E.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S294-S294
Databáze: ScienceDirect